Rolvedon Alternatives Compared
| Rolvedon (eflapegrastim) | Neulasta (pegfilgrastim) | Neupogen (filgrastim) |
|
|---|
| Rolvedon (eflapegrastim) | Neulasta (pegfilgrastim) | Neupogen (filgrastim) |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Neutropenia Associated with Chemotherapy. Rolvedon may also be used for purposes not listed in this medication guide. |
Prescription only
Neulasta is used to reduce the risk of infection in people with non-myeloid malignancies receiving bone marrow-suppressing anti-cancer drugs associated with a high risk of febrile neutropenia or to... View more |
Prescription only
Prescribed for Neutropenia Associated with Chemotherapy, Neutropenia, Peripheral Progenitor Cell Transplantation, Bone Marrow Transplantation, Neutropenia Associated with Radiation, Hematopoietic... View more |
Related suggestions Neutropenia Associated with Chemotherapy
|
|||||||||||||||||||||||
| More about Rolvedon (eflapegrastim) | More about Neulasta (pegfilgrastim) | More about Neupogen (filgrastim) | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Rolvedon has an average rating of 1.0 out of 10 from a total of 1 ratings on Drugs.com. 0% of reviewers reported a positive effect, while 100% reported a negative effect. |
Neulasta has an average rating of 5.1 out of 10 from a total of 71 ratings on Drugs.com. 42% of reviewers reported a positive effect, while 45% reported a negative effect. |
Neupogen has an average rating of 10.0 out of 10 from a total of 3 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
|
View all Rolvedon side effects |
View all Neulasta side effects |
View all Neupogen side effects |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Rolvedon prices |
View all Neulasta prices |
View all Neupogen prices |
||||||||||||||||||||||||
| Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
|
N/A |
Other pegfilgrastim brands include: Fulphila, Fylnetra, Nyvepria, Stimufend, Udenyca, Ziextenzo | Other filgrastim brands include: Nivestym, Nypozi, Releuko, Zarxio | ||||||||||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
|
36.4 hours |
80 hours |
5.8 hours |
||||||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 178 drugs are known to interact with Rolvedon:
|
A total of 178 drugs are known to interact with Neulasta:
|
A total of 175 drugs are known to interact with Neupogen:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
|
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
September 09, 2022 |
January 31, 2002 |
February 20, 1991 |
||||||||||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient Resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.